Cipla faces penalty of over Rs 1 Cr by GST authorities

Cipla, a leading pharmaceutical company, faces a penalty exceeding Rs 1 crore from the GST authorities for non-compliance with tax regulations. The penalty stems from discrepancies found during audits, where Cipla reportedly failed to meet certain GST filing and documentation requirements. Cipla, in its defense, stated that it had been making efforts to comply with all tax regulations. The company has appealed the penalty but emphasized its commitment to adhering to GST laws in the future. This move highlights the growing scrutiny of corporate tax practices by GST authorities and the importance of timely and accurate filings.